Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.08M Buy
18,998
+7,380
+64% +$1.07M ﹤0.01% 2600
2026
Q1
$1.37M Hold
11,618
﹤0.01% 3028
2025
Q4
$1.38M Buy
+11,618
New +$1.32M ﹤0.01% 2714
2024
Q2
Sell
-1,300
Closed -$227K 3228
2024
Q1
$227K Buy
+1,300
New +$213K ﹤0.01% 2665
2017
Q3
Sell
-95,757
Closed -$3.45M 3056
2017
Q2
$3.45M Buy
95,757
+39,915
+71% +$1.27M 0.01% 1067
2017
Q1
$1.48M Sell
55,842
-37,727
-40% -$920K 0.01% 1643
2016
Q4
$1.97M Buy
93,569
+33,680
+56% +$641K 0.01% 1503
2016
Q3
$1.04M Buy
59,889
+45,727
+323% +$753K ﹤0.01% 1937
2016
Q2
$215K Buy
+14,162
New +$218K ﹤0.01% 2716

Other funds holding NOVT

John Overdeck's NOVT Position: Q2 2026 in Review

John Overdeck increased its Novanta (NOVT) stake by 64% in Q2 2026, buying an estimated $1.07M and bringing the position to 18,998 shares worth $3.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2600.

John Overdeck first reported a position in NOVT in Q2 2016 and has held it in 9 quarters since. The position peaked at $3.45M in Q2 2017. 386 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.

  • John Overdeck held 18,998 shares of Novanta worth $3.08M as of Q2 2026.
  • John Overdeck bought 7,380 Novanta shares in Q2 2026, an estimated $1.07M.
  • Novanta made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2600 holding.
  • John Overdeck first reported a position in Novanta in Q2 2016 and has held it in 9 quarters since.
  • John Overdeck's Novanta position peaked at $3.45M in Q2 2017.
  • 386 funds tracked by Wall St. Rank held Novanta as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.